David Lock: Avastin and Lucentis—It’s time for NHS commissioners to act rationally by limiting the choices for wet AMD patients

The news that a Cochrane Review has concluded that Avastin (bevacizumab) is as safe as Lucentis (ranibizumab) to treat patients with wet age related macular degeneration (“wet AMD”), along with other studies that have shown the two drugs have broadly the same level of clinical effectiveness, comes as no surprise to those of us who have been […]

Read More…

David Lock: Do CCGs have the power to pay out for past PCT NHS continuing care errors?

The NHS has paid out vast amounts—probably hundreds of millions of pounds—in recent years as a result of decisions that patients were not entitled to NHS Continuing Care (where the NHS meets the costs of a package of social care and accommodation outside a hospital).  Mostly these are claims by relatives of deceased patients who […]

Read More…

David Lock on the landmark case concerning the future of Lewisham Hospital

The problem of how to tackle poor performing NHS trusts has dogged the NHS for many years. Companies that fail can be put into liquidation, factories close down, and people lose their jobs.  However, a failing hospital is not a factory.  An overspending hospital cannot “fail” and be closed because that would leave local people […]

Read More…